BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Comino I, Fernández-Bañares F, Esteve M, Ortigosa L, Castillejo G, Fambuena B, Ribes-Koninckx C, Sierra C, Rodríguez-Herrera A, Salazar JC, Caunedo Á, Marugán-Miguelsanz JM, Garrote JA, Vivas S, Lo Iacono O, Nuñez A, Vaquero L, Vegas AM, Crespo L, Fernández-Salazar L, Arranz E, Jiménez-García VA, Antonio Montes-Cano M, Espín B, Galera A, Valverde J, Girón FJ, Bolonio M, Millán A, Cerezo FM, Guajardo C, Alberto JR, Rosinach M, Segura V, León F, Marinich J, Muñoz-Suano A, Romero-Gómez M, Cebolla Á, Sousa C. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients. Am J Gastroenterol 2016;111:1456-65. [PMID: 27644734 DOI: 10.1038/ajg.2016.439] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Keir JLA, Cakmak S, Blais JM, White PA. The influence of demographic and lifestyle factors on urinary levels of PAH metabolites—empirical analyses of Cycle 2 (2009–2011) CHMS data. J Expo Sci Environ Epidemiol 2021;31:386-97. [DOI: 10.1038/s41370-020-0208-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Galli G, Carabotti M, Pilozzi E, Lahner E, Annibale B, Conti L. Relationship between Persistent Gastrointestinal Symptoms and Duodenal Histological Findings after Adequate Gluten-Free Diet: A Gray Area of Celiac Disease Management in Adult Patients. Nutrients 2021;13:600. [PMID: 33673062 DOI: 10.3390/nu13020600] [Reference Citation Analysis]
3 Singh A, Pramanik A, Acharya P, Makharia GK. Non-Invasive Biomarkers for Celiac Disease. J Clin Med 2019;8:E885. [PMID: 31234270 DOI: 10.3390/jcm8060885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
4 Monachesi C, Verma AK, Catassi GN, Franceschini E, Gatti S, Gesuita R, Lionetti E, Catassi C. Determination of Urinary Gluten Immunogenic Peptides to Assess Adherence to the Gluten-Free Diet: A Randomized, Double-Blind, Controlled Study. Clin Transl Gastroenterol 2021;12:e00411. [PMID: 34613954 DOI: 10.14309/ctg.0000000000000411] [Reference Citation Analysis]
5 Gładyś K, Dardzińska J, Guzek M, Adrych K, Małgorzewicz S. Celiac Dietary Adherence Test and Standardized Dietician Evaluation in Assessment of Adherence to a Gluten-Free Diet in Patients with Celiac Disease. Nutrients 2020;12:E2300. [PMID: 32751809 DOI: 10.3390/nu12082300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Therrien A, Leffler DA. Gluten immunogenic peptides: is knowing half the battle? The American Journal of Clinical Nutrition 2020;112:1147-8. [DOI: 10.1093/ajcn/nqaa228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Bai JC, Ciacci C. World Gastroenterology Organisation Global Guidelines: Celiac Disease February 2017. J Clin Gastroenterol. 2017;51:755-768. [PMID: 28877080 DOI: 10.1097/mcg.0000000000000919] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
8 Segura V, Ruiz-Carnicer Á, Sousa C, Moreno ML. New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options. Nutrients 2021;13:2146. [PMID: 34201435 DOI: 10.3390/nu13072146] [Reference Citation Analysis]
9 Söderström H, Rehn J, Cervin M, Ahlstermark C, Bybrant MC, Carlsson A. Compliance to a Gluten-Free Diet in Swedish Children with Type 1 Diabetes and Celiac Disease. Nutrients 2021;13:4444. [PMID: 34959996 DOI: 10.3390/nu13124444] [Reference Citation Analysis]
10 Tye-Din JA, Galipeau HJ, Agardh D. Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies. Front Pediatr 2018;6:350. [PMID: 30519552 DOI: 10.3389/fped.2018.00350] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
11 Nardo GD, Villa MP, Conti L, Ranucci G, Pacchiarotti C, Principessa L, Raucci U, Parisi P. Nutritional Deficiencies in Children with Celiac Disease Resulting from a Gluten-Free Diet: A Systematic Review. Nutrients 2019;11:1588. [DOI: 10.3390/nu11071588] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
12 Guzmán-López MH, Sánchez-León S, Marín-Sanz M, Comino I, Segura V, Vaquero L, Rivero-Lezcano OM, Pastor J, Sousa C, Vivas S, Barro F. Oral Consumption of Bread from an RNAi Wheat Line with Strongly Silenced Gliadins Elicits No Immunogenic Response in a Pilot Study with Celiac Disease Patients. Nutrients 2021;13:4548. [PMID: 34960101 DOI: 10.3390/nu13124548] [Reference Citation Analysis]
13 Rodríguez-Herrera A, Reyes-Andrade J, Rubio-Escudero C. Rationale for Timing of Follow-Up Visits to Assess Gluten-Free Diet in Celiac Disease Patients Based on Data Mining. Nutrients 2021;13:357. [PMID: 33503952 DOI: 10.3390/nu13020357] [Reference Citation Analysis]
14 Malamut G, Cording S, Cerf-Bensussan N. Recent advances in celiac disease and refractory celiac disease. F1000Res 2019;8:F1000 Faculty Rev-969. [PMID: 31297187 DOI: 10.12688/f1000research.18701.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
15 Coto L, Sousa C, Cebolla A. Dynamics and Considerations in the Determination of the Excretion of Gluten Immunogenic Peptides in Urine: Individual Variability at Low Gluten Intake. Nutrients 2021;13:2624. [PMID: 34444783 DOI: 10.3390/nu13082624] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Coto L, Mendia I, Sousa C, Bai JC, Cebolla A. Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: A systematic review. World J Gastroenterol 2021; 27(37): 6306-6321 [PMID: 34712034 DOI: 10.3748/wjg.v27.i37.6306] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Guzmán-López MH, Marín-Sanz M, Sánchez-León S, Barro F. A Bioinformatic Workflow for InDel Analysis in the Wheat Multi-Copy α-Gliadin Gene Family Engineered with CRISPR/Cas9. Int J Mol Sci 2021;22:13076. [PMID: 34884880 DOI: 10.3390/ijms222313076] [Reference Citation Analysis]
18 Wessels MM, te Lintelo M, Vriezinga SL, Putter H, Hopman EG, Mearin ML. Assessment of dietary compliance in celiac children using a standardized dietary interview. Clinical Nutrition 2018;37:1000-4. [DOI: 10.1016/j.clnu.2017.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
19 Dotsenko V, Oittinen M, Taavela J, Popp A, Peräaho M, Staff S, Sarin J, Leon F, Isola J, Mäki M, Viiri K. Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge. Cell Mol Gastroenterol Hepatol 2021;11:13-32. [PMID: 32745639 DOI: 10.1016/j.jcmgh.2020.07.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
20 Myléus A, Reilly NR, Green PHR. Rate, Risk Factors, and Outcomes of Nonadherence in Pediatric Patients With Celiac Disease: A Systematic Review.Clin Gastroenterol Hepatol. 2020;18:562-573. [PMID: 31173891 DOI: 10.1016/j.cgh.2019.05.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
21 Skodje GI, van Megen F, Stendahl M, Henriksen C, Lundin KEA, Veierød MB. Detection of gluten immunogenic peptides and the Celiac Disease Adherence Test to monitor gluten-free diet: a pilot study. Eur J Clin Nutr 2022. [PMID: 35001079 DOI: 10.1038/s41430-021-01054-6] [Reference Citation Analysis]
22 Freeman HJ. Dietary compliance in celiac disease. World J Gastroenterol 2017; 23(15): 2635-2639 [PMID: 28487600 DOI: 10.3748/wjg.v23.i15.2635] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 22] [Article Influence: 6.2] [Reference Citation Analysis]
23 Rodrigo L, Pérez-Martinez I, Lauret-Braña E, Suárez-González A. Descriptive Study of the Different Tools Used to Evaluate the Adherence to a Gluten-Free Diet in Celiac Disease Patients. Nutrients 2018;10:E1777. [PMID: 30453479 DOI: 10.3390/nu10111777] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
24 Pinto-Sanchez MI, Bai JC. Toward New Paradigms in the Follow Up of Adult Patients With Celiac Disease on a Gluten-Free Diet. Front Nutr 2019;6:153. [PMID: 31632977 DOI: 10.3389/fnut.2019.00153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
25 Moreno ML, Rodríguez-Herrera A, Sousa C, Comino I. Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Patients. Nutrients 2017;9:E46. [PMID: 28067823 DOI: 10.3390/nu9010046] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
26 Singh P, Silvester JA, Leffler D. (Outcome) Measure for (Intervention) Measures: A Guide to Choosing the Appropriate Noninvasive Clinical Outcome Measure for Intervention Studies in Celiac Disease. Gastroenterol Clin North Am 2019;48:85-99. [PMID: 30711213 DOI: 10.1016/j.gtc.2018.09.006] [Reference Citation Analysis]
27 Vaquero L, Comino I, Vivas S, Rodríguez-Martín L, Giménez MJ, Pastor J, Sousa C, Barro F. Tritordeum: a novel cereal for food processing with good acceptability and significant reduction in gluten immunogenic peptides in comparison with wheat. J Sci Food Agric 2018;98:2201-9. [PMID: 28963718 DOI: 10.1002/jsfa.8705] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
28 D'Avino P, Serena G, Kenyon V, Fasano A. An updated overview on celiac disease: from immuno-pathogenesis and immuno-genetics to therapeutic implications.Expert Rev Clin Immunol. 2021;17:269-284. [PMID: 33472447 DOI: 10.1080/1744666X.2021.1880320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Ismail MS, Semenov S, McNamara D. The utility of faecal and urine biomarkers for small bowel diseases. Curr Opin Gastroenterol 2021;37:284-94. [PMID: 33769381 DOI: 10.1097/MOG.0000000000000730] [Reference Citation Analysis]
30 Stefanolo JP, Tálamo M, Dodds S, de la Paz Temprano M, Costa AF, Moreno ML, Pinto-Sánchez MI, Smecuol E, Vázquez H, Gonzalez A, Niveloni SI, Mauriño E, Verdu EF, Bai JC. Real-World Gluten Exposure in Patients With Celiac Disease on Gluten-Free Diets, Determined From Gliadin Immunogenic Peptides in Urine and Fecal Samples. Clin Gastroenterol Hepatol 2021;19:484-491.e1. [PMID: 32217152 DOI: 10.1016/j.cgh.2020.03.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
31 Ludvigsson JF, Ciacci C, Green PH, Kaukinen K, Korponay-Szabo IR, Kurppa K, Murray JA, Lundin KEA, Maki MJ, Popp A, Reilly NR, Rodriguez-Herrera A, Sanders DS, Schuppan D, Sleet S, Taavela J, Voorhees K, Walker MM, Leffler DA. Outcome measures in coeliac disease trials: the Tampere recommendations. Gut. 2018;67:1410-1424. [PMID: 29440464 DOI: 10.1136/gutjnl-2017-314853] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 13.3] [Reference Citation Analysis]
32 Cebolla Á, Moreno ML, Coto L, Sousa C. Gluten Immunogenic Peptides as Standard for the Evaluation of Potential Harmful Prolamin Content in Food and Human Specimen. Nutrients 2018;10:E1927. [PMID: 30563126 DOI: 10.3390/nu10121927] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
33 Coto L, Sousa C, Cebolla A. Individual variability in patterns and dynamics of fecal gluten immunogenic peptides excretion after low gluten intake. Eur J Nutr 2022. [PMID: 34993643 DOI: 10.1007/s00394-021-02765-z] [Reference Citation Analysis]
34 Daveson AJM, Tye-Din JA, Goel G, Goldstein KE, Hand HL, Neff KM, Williams LJ, Truitt KE, Anderson RP; RESET CeD Study Group. Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Aliment Pharmacol Ther 2020;51:244-52. [PMID: 31769533 DOI: 10.1111/apt.15551] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
35 Rej A, Elli L, Sanders DS. Persisting Villous Atrophy and Adherence in Celiac Disease: What Does the Patient Want? What Should a Clinician Advise? Am J Gastroenterol 2021;116:946-8. [PMID: 33767095 DOI: 10.14309/ajg.0000000000001244] [Reference Citation Analysis]
36 Soderquist CR, Bhagat G. Cellular and molecular bases of refractory celiac disease. Int Rev Cell Mol Biol 2021;358:207-40. [PMID: 33707055 DOI: 10.1016/bs.ircmb.2020.12.001] [Reference Citation Analysis]
37 Cheng FW, Handu D. Nutrition Assessment, Interventions, and Monitoring for Patients with Celiac Disease: An Evidence Analysis Center Scoping Review. J Acad Nutr Diet 2020;120:1381-406. [PMID: 31953154 DOI: 10.1016/j.jand.2019.09.019] [Reference Citation Analysis]
38 Neuman V, Pruhova S, Kulich M, Kolouskova S, Vosahlo J, Romanova M, Petruzelkova L, Obermannova B, Funda DP, Cinek O, Sumnik Z. Gluten‐free diet in children with recent‐onset type 1 diabetes: A 12‐month intervention trial. Diabetes Obes Metab 2020;22:866-72. [DOI: 10.1111/dom.13974] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
39 Remes-Troche JM, Uscanga-Domínguez LF, Aceves-Tavares RG, Calderón de la Barca AM, Carmona-Sánchez RI, Cerda-Contreras E, Coss-Adame E, Icaza-Chávez ME, Lopéz-Colombo A, Milke-García MP, Morales-Arámbula M, Peláez-Luna M, Ramos Martínez P, Sánchez-Sosa S, Treviño-Mejía MC, Vázquez-Frías R, Worona-Dibner LB, Zamora-Nava LE, Rubio-Tapia A. Clinical guidelines on the diagnosis and treatment of celiac disease in Mexico. Rev Gastroenterol Mex (Engl Ed) 2018;83:434-50. [PMID: 30197183 DOI: 10.1016/j.rgmx.2018.05.005] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
40 Silvester JA, Kurada S, Szwajcer A, Kelly CP, Leffler DA, Duerksen DR. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis. Gastroenterology 2017; 153: 689-701. e1. [PMID: 28545781 DOI: 10.1053/j.gastro.2017.05.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 13.8] [Reference Citation Analysis]
41 Scherf KA, Catassi C, Chirdo F, Ciclitira PJ, Feighery C, Gianfrani C, Koning F, Lundin KEA, Schuppan D, Smulders MJM, Tranquet O, Troncone R, Koehler P. Recent Progress and Recommendations on Celiac Disease From the Working Group on Prolamin Analysis and Toxicity. Front Nutr 2020;7:29. [PMID: 32258047 DOI: 10.3389/fnut.2020.00029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
42 Wieser H, Ruiz-Carnicer Á, Segura V, Comino I, Sousa C. Challenges of Monitoring the Gluten-Free Diet Adherence in the Management and Follow-Up of Patients with Celiac Disease. Nutrients 2021;13:2274. [PMID: 34209138 DOI: 10.3390/nu13072274] [Reference Citation Analysis]
43 Hujoel IA, Murray JA. Refractory Celiac Disease.Curr Gastroenterol Rep. 2020;22:18. [PMID: 32185560 DOI: 10.1007/s11894-020-0756-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
44 Wessels M, Auricchio R, Dolinsek J, Donat E, Gillett P, Mårild K, Meijer C, Popp A, Mearin ML. Review on pediatric coeliac disease from a clinical perspective. Eur J Pediatr 2022. [PMID: 35034201 DOI: 10.1007/s00431-022-04379-x] [Reference Citation Analysis]
45 Packova B, Kovalcikova P, Pavlovsky Z, Bartusek D, Prokesova J, Dolina J, Kroupa R. Non-invasive prediction of persistent villous atrophy in celiac disease. World J Gastroenterol 2020; 26(26): 3780-3791 [PMID: 32774057 DOI: 10.3748/wjg.v26.i26.3780] [Reference Citation Analysis]
46 Cichewicz AB, Mearns ES, Taylor A, Boulanger T, Gerber M, Leffler DA, Drahos J, Sanders DS, Thomas Craig KJ, Lebwohl B. Diagnosis and Treatment Patterns in Celiac Disease. Dig Dis Sci. 2019;. [PMID: 30820708 DOI: 10.1007/s10620-019-05528-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
47 Syage JA, Kelly CP, Dickason MA, Ramirez AC, Leon F, Dominguez R, Sealey-Voyksner JA. Determination of gluten consumption in celiac disease patients on a gluten-free diet. Am J Clin Nutr. 2018;107:201-207. [PMID: 29529159 DOI: 10.1093/ajcn/nqx049] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 15.7] [Reference Citation Analysis]
48 Nardecchia S, Auricchio R, Discepolo V, Troncone R. Extra-Intestinal Manifestations of Coeliac Disease in Children: Clinical Features and Mechanisms. Front Pediatr. 2019;7:56. [PMID: 30891436 DOI: 10.3389/fped.2019.00056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
49 Itzlinger A, Branchi F, Elli L, Schumann M. Gluten-Free Diet in Celiac Disease-Forever and for All? Nutrients 2018;10:E1796. [PMID: 30453686 DOI: 10.3390/nu10111796] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
50 Rej A, Aziz I, Sanders DS. Personalizing Dietary Therapies For Irritable Bowel Syndrome: What Is Gluten's Role? Clin Gastroenterol Hepatol 2021;19:2270-3. [PMID: 33069879 DOI: 10.1016/j.cgh.2020.10.024] [Reference Citation Analysis]
51 Fernández Miaja M, Díaz Martín JJ, Jiménez Treviño S, Suárez González M, Bousoño García C. Study of adherence to the gluten-free diet in coeliac patients. An Pediatr (Engl Ed) 2021;94:377-84. [PMID: 34090634 DOI: 10.1016/j.anpede.2020.06.012] [Reference Citation Analysis]
52 Veeraraghavan G, Therrien A, Degroote M, McKeown A, Mitchell PD, Silvester JA, Leffler DA, Leichtner AM, Kelly CP, Weir DC. Non-responsive celiac disease in children on a gluten free diet. World J Gastroenterol 2021; 27(13): 1311-1320 [PMID: 33833484 DOI: 10.3748/wjg.v27.i13.1311] [Reference Citation Analysis]
53 Zysk W, Głąbska D, Guzek D. Social and Emotional Fears and Worries Influencing the Quality of Life of Female Celiac Disease Patients Following a Gluten-Free Diet. Nutrients 2018;10:E1414. [PMID: 30282900 DOI: 10.3390/nu10101414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
54 Losurdo G, Gravina AG, Maroni L, Gabrieletto EM, Ianiro G, Ferrarese A; Young Investigator group of SIGE, the Italian Society of Gastroenterology. Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective. Dig Liver Dis 2021:S1590-8658(21)00455-2. [PMID: 34509394 DOI: 10.1016/j.dld.2021.08.008] [Reference Citation Analysis]
55 García-Molina MD, Giménez MJ, Sánchez-León S, Barro F. Gluten Free Wheat: Are We There? Nutrients 2019;11:E487. [PMID: 30813572 DOI: 10.3390/nu11030487] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 8.3] [Reference Citation Analysis]
56 Aljada B, Zohni A, El-Matary W. The Gluten-Free Diet for Celiac Disease and Beyond. Nutrients 2021;13:3993. [PMID: 34836247 DOI: 10.3390/nu13113993] [Reference Citation Analysis]
57 Ramírez-Sánchez AD, Tan IL, Gonera-de Jong BC, Visschedijk MC, Jonkers I, Withoff S. Molecular Biomarkers for Celiac Disease: Past, Present and Future. Int J Mol Sci 2020;21:E8528. [PMID: 33198309 DOI: 10.3390/ijms21228528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Garcia-peris M, Donat Aliaga E, Roca Llorens M, Masip Simó E, Polo Miquel B, Ribes Koninckx C. Anti-tissue transglutaminase antibodies not related to gluten intake. Anales de Pediatría (English Edition) 2018;89:279-85. [DOI: 10.1016/j.anpede.2018.01.011] [Reference Citation Analysis]
59 Malamut G, Cellier C. Refractory Celiac Disease. Gastroenterology Clinics of North America 2019;48:137-44. [DOI: 10.1016/j.gtc.2018.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
60 Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391:70-81. [PMID: 28760445 DOI: 10.1016/s0140-6736(17)31796-8] [Cited by in Crossref: 333] [Cited by in F6Publishing: 146] [Article Influence: 66.6] [Reference Citation Analysis]
61 Gerasimidis K, Zafeiropoulou K, Mackinder M, Ijaz UZ, Duncan H, Buchanan E, Cardigan T, Edwards CA, McGrogan P, Russell RK. Comparison of Clinical Methods With the Faecal Gluten Immunogenic Peptide to Assess Gluten Intake in Coeliac Disease. J Pediatr Gastroenterol Nutr 2018;67:356-60. [PMID: 29916953 DOI: 10.1097/MPG.0000000000002062] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
62 Silvester JA, Comino I, Rigaux LN, Segura V, Green KH, Cebolla A, Weiten D, Dominguez R, Leffler DA, Leon F, Bernstein CN, Graff LA, Kelly CP, Sousa C, Duerksen DR. Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten-free diet.Aliment Pharmacol Ther. 2020;52:1469-1479. [PMID: 32981131 DOI: 10.1111/apt.16075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
63 van der Fels-Klerx HJ, Smits NGE, Bremer MGEG, Schultink JM, Nijkamp MM, Castenmiller JJM, de Vries JHM. Detection of gluten in duplicate portions to determine gluten intake of coeliac disease patients on a gluten-free diet. Br J Nutr 2021;125:1051-7. [PMID: 32723408 DOI: 10.1017/S0007114520002974] [Reference Citation Analysis]
64 De Re V, Magris R, Cannizzaro R. New Insights into the Pathogenesis of Celiac Disease. Front Med (Lausanne) 2017;4:137. [PMID: 28913337 DOI: 10.3389/fmed.2017.00137] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
65 Larussa T, Boccuto L, Luzza F, Abenavoli L. Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients. Minerva Gastroenterol (Torino) 2021;67:69-71. [PMID: 32403893 DOI: 10.23736/S2724-5985.20.02710-5] [Reference Citation Analysis]
66 Elli L, Ferretti F, Orlando S, Vecchi M, Monguzzi E, Roncoroni L, Schuppan D. Management of celiac disease in daily clinical practice.Eur J Intern Med. 2019;61:15-24. [PMID: 30528262 DOI: 10.1016/j.ejim.2018.11.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
67 Ruiz-Carnicer Á, Garzón-Benavides M, Fombuena B, Segura V, García-Fernández F, Sobrino-Rodríguez S, Gómez-Izquierdo L, Montes-Cano MA, Rodríguez-Herrera A, Millán R, Rico MC, González-Naranjo C, Bozada-García JM, Díaz J, Coronel-Rodríguez C, Espín B, Romero-Gómez M, Cebolla Á, Sousa C, Comino I, Argüelles F, Pizarro Á. Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: new proposals for follow-up in celiac disease. Am J Clin Nutr 2020;112:1240-51. [PMID: 32692806 DOI: 10.1093/ajcn/nqaa188] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
68 Therrien A, Silvester JA, Leonard MM, Leffler DA, Fasano A, Kelly CP. Enteric-Release Budesonide May Be Useful in the Management of Non-Responsive Celiac Disease. Dig Dis Sci 2021;66:1989-97. [PMID: 32654085 DOI: 10.1007/s10620-020-06454-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Moreno Amador ML, Arévalo-Rodríguez M, Durán EM, Martínez Reyes JC, Sousa Martín C. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides. PLoS One 2019;14:e0218346. [PMID: 31246975 DOI: 10.1371/journal.pone.0218346] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
70 Ciacci C, Gagliardi M, Siniscalchi M, Ruotolo M, Santonicola A, Hajji N, Zingone F. Gluten Immunogenic Peptides (GIP) Point-of-Care Urine Test in Coeliac Disease Follow-up before and during the COVID-19 Lockdown in Italy. Clin Exp Gastroenterol 2021;14:451-6. [PMID: 34815686 DOI: 10.2147/CEG.S326137] [Reference Citation Analysis]
71 Cartee AK, Choung RS, King KS, Wang S, Dzuris JL, Anderson RP, Van Dyke CT, Hinson CA, Marietta E, Katzka DA, Nehra V, Grover M, Murray JA. Plasma IL-2 and Symptoms Response after Acute Gluten Exposure in Subjects With Celiac Disease or Nonceliac Gluten Sensitivity. Am J Gastroenterol 2021. [PMID: 34797778 DOI: 10.14309/ajg.0000000000001565] [Reference Citation Analysis]
72 Gangadoo S, Rajapaksha Pathirannahalage P, Cheeseman S, Dang YTH, Elbourne A, Cozzolino D, Latham K, Truong VK, Chapman J. The Multiomics Analyses of Fecal Matrix and Its Significance to Coeliac Disease Gut Profiling. Int J Mol Sci 2021;22:1965. [PMID: 33671197 DOI: 10.3390/ijms22041965] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Comino I, Segura V, Ortigosa L, Espín B, Castillejo G, Garrote JA, Sierra C, Millán A, Ribes-Koninckx C, Román E, Rodríguez-Herrera A, Díaz J, Silvester JA, Cebolla Á, Sousa C. Prospective longitudinal study: use of faecal gluten immunogenic peptides to monitor children diagnosed with coeliac disease during transition to a gluten-free diet. Aliment Pharmacol Ther 2019;49:1484-92. [PMID: 31074004 DOI: 10.1111/apt.15277] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
74 Tompa A, Åkesson K, Karlsson S, Faresjö M. Suppressed immune profile in children with combined type 1 diabetes and celiac disease. Clin Exp Immunol 2020;201:244-57. [PMID: 32415995 DOI: 10.1111/cei.13454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Kaur A, Shimoni O, Wallach M. Celiac disease: from etiological factors to evolving diagnostic approaches. J Gastroenterol 2017;52:1001-12. [PMID: 28631048 DOI: 10.1007/s00535-017-1357-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
76 Silvester JA, Graff LA, Rigaux L, Bernstein CN, Leffler DA, Kelly CP, Walker JR, Duerksen DR. Symptoms of Functional Intestinal Disorders Are Common in Patients with Celiac Disease Following Transition to a Gluten-Free Diet. Dig Dis Sci 2017;62:2449-54. [PMID: 28687943 DOI: 10.1007/s10620-017-4666-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
77 Lauxmann MA, Vazquez DS, Schilbert HM, Neubauer PR, Lammers KM, Dodero VI. From celiac disease to coccidia infection and vice-versa: The polyQ peptide CXCR3-interaction axis. Bioessays 2021;43:e2100101. [PMID: 34705290 DOI: 10.1002/bies.202100101] [Reference Citation Analysis]
78 Costa AF, Sugai E, Temprano MLP, Niveloni SI, Vázquez H, Moreno ML, Domínguez-Flores MR, Muñoz-Suano A, Smecuol E, Stefanolo JP, González AF, Cebolla-Ramirez A, Mauriño E, Verdú EF, Bai JC. Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients. World J Gastroenterol 2019; 25(11): 1409-1420 [PMID: 30918433 DOI: 10.3748/wjg.v25.i11.1409] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
79 Fernández-Bañares F, Beltrán B, Salas A, Comino I, Ballester-Clau R, Ferrer C, Molina-Infante J, Rosinach M, Modolell I, Rodríguez-Moranta F, Arau B, Segura V, Fernández-Salazar L, Santolaria S, Esteve M, Sousa C; CADER study group. Persistent Villous Atrophy in De Novo Adult Patients With Celiac Disease and Strict Control of Gluten-Free Diet Adherence: A Multicenter Prospective Study (CADER Study). Am J Gastroenterol 2021;116:1036-43. [PMID: 33491958 DOI: 10.14309/ajg.0000000000001139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Porcelli B, Ferretti F, Biviano I, Santini A, Cinci F, Vascotto M, Grande E, Quagliarella F, Terzuoli L, Bizzaro N, Marini M, Rentini S. Testing for fecal gluten immunogenic peptides: a useful tool to evaluate compliance with gluten-free diet by celiacs. Ann Gastroenterol 2020;33:631-7. [PMID: 33162739 DOI: 10.20524/aog.2020.0530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Laurikka P, Kaukinen K, Kurppa K. Unravelling the mechanisms behind the persistent gastrointestinal symptoms in celiac disease – how can they lead to better treatment outcomes? Expert Review of Gastroenterology & Hepatology 2017;11:605-7. [DOI: 10.1080/17474124.2017.1312345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Muhammad H, Reeves S, Jeanes YM. Identifying and improving adherence to the gluten-free diet in people with coeliac disease.Proc Nutr Soc. 2019;78:418-425. [PMID: 30630540 DOI: 10.1017/S002966511800277X] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
83 Ediger TR, Hill ID. Celiac Disease. Pediatr Rev 2021;42:529-38. [PMID: 34599052 DOI: 10.1542/pir.2020-000711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Fernández Miaja M, Díaz Martín JJ, Jiménez Treviño S, Suárez González M, Bousoño García C. [Study of adherence to the gluten-free diet in coeliac patients].An Pediatr (Barc). 2021;94:377-384. [PMID: 32830086 DOI: 10.1016/j.anpedi.2020.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
85 Khosla C. Celiac Disease: Lessons for and from Chemical Biology. ACS Chem Biol 2017;12:1455-9. [PMID: 28165712 DOI: 10.1021/acschembio.6b01155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
86 Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, Collin P, Green PHR, Crowe SE, Tsuji W, Butz E, Cerf-Bensussan N, Macintyre E, Parnes JR, Leon F, Hermine O, Mulder CJ; RCD-II Study Group Investigators. Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.Lancet Gastroenterol Hepatol. 2019;4:960-970. [PMID: 31494097 DOI: 10.1016/S2468-1253(19)30265-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 9.3] [Reference Citation Analysis]
87 Porcelli B, Ferretti F, Cinci F, Biviano I, Santini A, Grande E, Quagliarella F, Terzuoli L, Bacarelli MR, Bizzaro N, Vascotto M, Marini M. Fecal gluten immunogenic peptides as indicators of dietary compliance in celiac patients. Minerva Gastroenterol Dietol 2020;66:201-7. [PMID: 32218420 DOI: 10.23736/S1121-421X.20.02662-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
88 Garcia-Peris M, Donat Aliaga E, Roca Llorens M, Masip Simó E, Polo Miquel B, Ribes Koninckx C. [Anti-tissue transglutaminase antibodies not related to gluten intake]. An Pediatr (Engl Ed) 2018;89:279-85. [PMID: 29555204 DOI: 10.1016/j.anpedi.2018.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]